Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04809714 · ClinicalTrials.gov registry record · NA
The Role of Blood Flow Restriction Therapy in Postoperative Elderly Patients With Hip Fracture
A NA study of Hip Fractures and Muscle Atrophy, sponsored by University of Alabama at Birmingham.
- Active
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT04809714 is a NA study of Hip Fractures and Muscle Atrophy that is active but no longer recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 20 participants, below the 620-participant average among 15 other Hip Fractures trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04809714, a NA study of Hip Fractures and Muscle Atrophy, is active but no longer recruiting, sponsored by University of Alabama at Birmingham.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators aim to study the use of blood flow restriction therapy (BFR) to augment routine post-operative physical therapy in elderly patients (age \>= 65) after recovering from surgical treatment of hip fractures.
Conditions Studied
Interventions
- DEVICE Blood Flow Restriction with Delfi Tourniquet System Cuff
- OTHER Routine Post-operative Physical Therapy
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-01-01 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04809714
The ClinicalTrials.gov registry entry for NCT04809714 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 620-participant average among 15 other Hip Fractures trials with a reported enrollment target (97% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Hip Fractures appearing as the primary indexed condition, and to 2 interventions - of which Blood Flow Restriction with Delfi Tourniquet System Cuff is the first listed.
NCT04809714 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT04809714 about?
NCT04809714 is a clinical study titled "The Role of Blood Flow Restriction Therapy in Postoperative Elderly Patients With Hip Fracture". The investigators aim to study the use of blood flow restriction therapy (BFR) to augment routine post-operative physical therapy in elderly patients (age \>= 65) after recovering from surgical treatment of hip fractures.
What is the current status of trial NCT04809714?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2022-01-01. Estimated completion is 2027-12-31.
What conditions does trial NCT04809714 study?
This clinical trial studies the following conditions: Hip Fractures, Muscle Atrophy.
What interventions are being tested in trial NCT04809714?
The interventions under investigation include: Blood Flow Restriction with Delfi Tourniquet System Cuff (DEVICE), Routine Post-operative Physical Therapy (OTHER).
Who is sponsoring clinical trial NCT04809714?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04809714 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hip Fractures
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
RECRUITING · NA
-
Evaluating a Strategy to Improve Pre-Anesthesia Care Discussions (My Anesthesia Choice-Hip Fracture)
RECRUITING · NA
-
Cervical Myelopathy in Hip Fracture Patients
RECRUITING · NA
-
PENG vs Femoral Block for Hip Fracture Analgesia
RECRUITING · NA
-
Evaluating the Efficacy of a Mobile Application in Postoperative Rehabilitation
RECRUITING · NA
-
Utility of Cortical Bone Tissue Properties in the Assessment of Fracture Risk
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.